Next Article in Journal
Gold Nanoparticle-Mediated Gene Therapy
Next Article in Special Issue
BRCA1/2 Mutation Testing in Patients with HER2-Negative Advanced Breast Cancer: Real-World Data from the United States, Europe, and Israel
Previous Article in Journal
Transcriptomic Profiling of Breast Cancer Cells Induced by Tumor-Associated Macrophages Generates a Robust Prognostic Gene Signature
Previous Article in Special Issue
Temporal Heterogeneity of HER2 Expression and Spatial Heterogeneity of 18F-FDG Uptake Predicts Treatment Outcome of Pyrotinib in Patients with HER2-Positive Metastatic Breast Cancer
 
 
Article

Article Versions Notes

Cancers 2022, 14(21), 5365; https://doi.org/10.3390/cancers14215365
Action Date Notes Link
article xml file uploaded 31 October 2022 10:19 CET Original file -
article xml uploaded. 31 October 2022 10:19 CET Update -
article pdf uploaded. 31 October 2022 10:19 CET Version of Record https://www.mdpi.com/2072-6694/14/21/5365/pdf-vor
article html file updated 31 October 2022 10:20 CET Original file -
article xml file uploaded 31 October 2022 10:36 CET Update -
article xml uploaded. 31 October 2022 10:36 CET Update -
article pdf uploaded. 31 October 2022 10:36 CET Updated version of record https://www.mdpi.com/2072-6694/14/21/5365/pdf-vor
article html file updated 31 October 2022 10:38 CET Update -
article xml file uploaded 1 November 2022 10:30 CET Update -
article xml uploaded. 1 November 2022 10:30 CET Update https://www.mdpi.com/2072-6694/14/21/5365/xml
article pdf uploaded. 1 November 2022 10:30 CET Updated version of record https://www.mdpi.com/2072-6694/14/21/5365/pdf
article html file updated 1 November 2022 10:32 CET Update -
article html file updated 28 February 2023 20:46 CET Update -
article html file updated 2 March 2023 01:48 CET Update https://www.mdpi.com/2072-6694/14/21/5365/html
Back to TopTop